Allegedly Infringing Product Continues to be on Clinical Tri

Allegedly Infringing Product Continues to be on Clinical Trial RaDaRs  | Irwin IP LLP

Rs Natera, Inc. v. NeoGenomics Laboratories, Inc., 23-cv-00629 (M.D.N.C. 2023) - How should courts resolve patent infringement disputes where patients rely on allegedly...

Related Keywords

North Carolina , United States , , Neogenomics Laboratories Inc , Rs Natera Inc , Us District Court , District Of North Carolina The Court , Genomics Laboratories , Middle District ,

© 2025 Vimarsana